Print

MEDA: Zyclara Filed in Europe  
6/23/2011 9:34:27 AM

The marketing authorization application for the patented product Zyclara (imiquimod 3.75% cream) has been filed with the European Medicines Agency (EMA). Zyclara has been documented for once-daily topical treatment of actinic keratosis (AK).
//-->